The proteome microenvironment determines the protective effect of preconditioning in cisplatin-induced acute kidney injury

1. Download high-res image (341KB)
2. Download full-size image

     

Mock jurors’ awareness of age-related changes in memory and cognitive capacity

While age-related changes in memory have been well documented, findings about jurors’ perceptions of older witnesses are conflicting. We investigated the effect of victim age (25 vs. 75?years old) and crime severity (victim injured vs. not injured) on mock jurors’ decisions in a robbery trial. Jury-eligible participants (120 women; 84 men) read a mock trial summary and delivered their verdicts online. Mock jurors believed the young victim more than the older victim when the crime was severe, while no age differences emerged for the less severe crime. Whereas previous research demonstrated that juror characteristics were generally associated with culpability, we demonstrated that with case-specific information, these general views became less important. In all, mock jurors were aware of age-related decline in memory provided by eyewitnesses only to a limited extent. Accordingly, in trials involving older witnesses, jurors will benefit from educative information about age-related memory changes.     

Clinicopathologic Evaluation of Cardiofaciocutaneous Syndrome: Overcoming the Challenges of Diagnosing a Rare Genodermatosis

We report the case of a 2‐year‐old boy from a family with limited financial resources who presented with cutaneous abnormalities, a history of congenital heart defect, and a presumptive diagnosis of Noonan syndrome. Genetic testing had been deferred because of a lack of funds. Skin findings were characteristic of cardiofaciocutaneous syndrome, including keratosis pilaris, ichthyosis, sparse eyebrows, and multiple nevi. A biopsy of a perifollicular thick papule with background hyperpigmentation was obtained to further characterize the cutaneous findings. Clinical evaluation allowed rapid, cost‐effective, specific diagnosis in this patient with a RASopathy‐spectrum genetic disorder who did not have access to genetic testing. This time‐honored clinical approach is adequate for providing information important for prognosis, follow‐up, and counseling. We will also discuss available resources for genetic testing and specialized care for patients with RASopathies.     

Can EGFR mutation status be reliably determined in pre‐operative needle biopsies from adenocarcinomas of the lung?

The identification of EGFR mutations in non‐small‐cell lung cancer is important for selecting patients, who may benefit from treatment with EGFR tyrosine kinase inhibitors. The analysis is usually performed on cytological aspirates and/or histological needle biopsies, representing a small fraction of the tumour volume. The aim of the present investigation was to evaluate the diagnostic performance of this molecular test. We retrospectively included 201 patients with primary adenocarcinoma of the lung. EGFR mutation status (exon 19 deletions and exon 21 L858R point mutation) was evaluated on both pre‐operative biopsies (131 histological and 70 cytological) and on the surgical specimens, using PCR. Samples with low tumour cell fraction were assigned to laser micro‐dissection (LMD). We found nine (4.5%) patients with EGFR mutation in the lung tumour resections, but failed to identify mutation in one of the corresponding pre‐operative, cytological specimens. Several (18.4%) analyses of the pre‐operative biopsies were inconclusive, especially in case of biopsies undergoing LMD and regarding exon 21 analysis. Discrepancy of mutation status in one patient may reflect intra‐tumoural heterogeneity or technical issues. Moreover, several inconclusive results in the diagnostic biopsies reveal that attention must be paid on the suitability of pre‐operative biopsies for EGFR mutation analysis.